EDIT
Price
$3.15
Change
-$0.11 (-3.37%)
Updated
Jul 25 closing price
Capitalization
263.7M
3 days until earnings call
RPTX
Price
$1.56
Change
+$0.01 (+0.65%)
Updated
Jul 25 closing price
Capitalization
66.91M
10 days until earnings call
Interact to see
Advertisement

EDIT vs RPTX

Header iconEDIT vs RPTX Comparison
Open Charts EDIT vs RPTXBanner chart's image
Editas Medicine
Price$3.15
Change-$0.11 (-3.37%)
Volume$1.28M
Capitalization263.7M
Repare Therapeutics
Price$1.56
Change+$0.01 (+0.65%)
Volume$101.58K
Capitalization66.91M
EDIT vs RPTX Comparison Chart in %
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. RPTX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and RPTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (EDIT: $3.15 vs. RPTX: $1.56)
Brand notoriety: EDIT and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 47% vs. RPTX: 27%
Market capitalization -- EDIT: $263.7M vs. RPTX: $66.91M
EDIT [@Biotechnology] is valued at $263.7M. RPTX’s [@Biotechnology] market capitalization is $66.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while RPTX’s TA Score has 4 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 4 bearish.
  • RPTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RPTX is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а +14.13% price change this week, while RPTX (@Biotechnology) price change was +3.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

EDIT is expected to report earnings on Jul 30, 2025.

RPTX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($264M) has a higher market cap than RPTX($66.9M). EDIT YTD gains are higher at: 148.032 vs. RPTX (19.084). RPTX has higher annual earnings (EBITDA): -128.28M vs. EDIT (-244.52M). EDIT has more cash in the bank: 221M vs. RPTX (124M). RPTX has less debt than EDIT: RPTX (1.37M) vs EDIT (31.1M). EDIT has higher revenues than RPTX: EDIT (35.8M) vs RPTX (1.07M).
EDITRPTXEDIT / RPTX
Capitalization264M66.9M395%
EBITDA-244.52M-128.28M191%
Gain YTD148.03219.084776%
P/E RatioN/AN/A-
Revenue35.8M1.07M3,336%
Total Cash221M124M178%
Total Debt31.1M1.37M2,267%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITRPTX
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 7 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IMIMF0.07N/A
+7.45%
Copper Quest Expl Inc
ASHTF69.000.82
+1.21%
Ashtead Group PLC
HUGPF46.36N/A
N/A
Hugo Boss AG
KWHAF0.24N/A
N/A
K. Wah International Holdings Ltd.
MNNGF0.08N/A
N/A
Affluent Partners Holdings Ltd.

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRSP. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-3.37%
CRSP - EDIT
53%
Loosely correlated
-1.97%
NTLA - EDIT
49%
Loosely correlated
+6.38%
RXRX - EDIT
48%
Loosely correlated
+3.67%
PRME - EDIT
47%
Loosely correlated
-3.22%
SLDB - EDIT
47%
Loosely correlated
+4.79%
More

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+0.65%
INO - RPTX
51%
Loosely correlated
-2.65%
BCYC - RPTX
48%
Loosely correlated
+1.16%
CADL - RPTX
44%
Loosely correlated
+0.29%
EDIT - RPTX
35%
Loosely correlated
-3.37%
BOLD - RPTX
33%
Poorly correlated
+1.20%
More